verve therapeutics stock forecast

Shares of Verve Therapeutics stock opened at 2338 on Thursday. Verve Therapeutics NASDAQVERV has a recorded net income of -12031 million.

Ibm Stock Price Awaits Q2 2021 Earnings Vpt

1 day and results in a price target of 1969.

. Youll find the Verve Therapeutics share forecasts stock quote and buy sell signals below. Verve Therapeutics Stock Prediction. On average analysts forecast that.

VERV has generated -290 earnings per share over the last four quarters. The forecast for the further price development based on current price information is -011 time horizon. The Score for VERV is 54 which is 8 above its historic median score of 50 and infers lower risk than normal.

Verve Therapeutics Provides Regulatory Update on VERVE-101 Investigational New Drug Application and Reports Third Quarter 2022 Financial Results. Verve Therapeutics has a 52 week low of 1070 and a 52 week high of 5096. Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease transforming treatment from chronic management to single.

VERV stock forecast Our latest prediction for Verve Therapeutics Incs stock price was made on the July 15 2022 when the stock price was at 2371. The data shows that as of Oct 13 2022 short interest in Verve Therapeutics Inc. According to 15 stock analysts the average 12-month stock price forecast for VERV stock is 5419 which predicts an increase of 752.

The lowest target is 3636 and. VERV stood at 1790 of shares outstanding with shares short rising to 986 million. Shares of Verve Therapeutics Inc.

The current Verve Therapeutics VERV share price is 3634. In the short term. Cash burn is approximately 45 m a quarter.

On average analysts forecast that VERVs EPS will be -298 for 2022 with the lowest EPS forecast at -321 and the highest EPS forecast at -274. NASDAQVERV - Get Rating - Analysts at Jefferies Financial Group cut their FY2022 earnings estimates for shares of Verve Therapeutics in a. The current Verve Therapeutics VERV share price is 3232.

NASDAQVERV Get Rating shot up 138 on Friday. As of 2022 October 27 Thursday current price of VERV stock is 37000 and our data indicates that the asset price has been in a downtrend. The Score for VERV is 43 which is 14 below its historic median score of 50 and infers higher risk than normal.

The further forecasts for. Verve Therapeutics Market Cap. Wall Street Stock Market Finance report prediction for the future.

The company traded as high as 2698 and last traded at 2660. Verve Therapeutics Inc NASDAQVERV 3459 Delayed Data As of 402pm ET -185 -508 Todays Change 1070 Today 52-Week Range 5618 -618 Year-to-Date Quote Profile News. November 7 2022 at.

VERV Stock Price Prediction 5117 11886 Upside Based on 6 Wall Street analysts offering 12 month price targets for Verve Therapeutics in the last 3 months. The average price target is. Verve Therapeutics Inc.

About the Verve Therapeutics Inc stock forecast. Verve Therapeutics is well-capitalized and reported 550 million in cash which they expect to provide funding into 2025.

Verv Stock Forecast Price News Verve Therapeutics